GENTEX CORP (GNTX)

US3719011096 - Common Stock

29.15  +0.02 (+0.07%)

After market: 29.15 0 (0%)

Fundamental Rating

7

GNTX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 82 industry peers in the Automobile Components industry. GNTX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. GNTX is valied quite expensively at the moment, while it does show a decent growth rate. These ratings would make GNTX suitable for quality investing!



8

1. Profitability

1.1 Basic Checks

GNTX had positive earnings in the past year.
In the past year GNTX had a positive cash flow from operations.
GNTX had positive earnings in each of the past 5 years.
GNTX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

GNTX has a Return On Assets of 19.53%. This is amongst the best in the industry. GNTX outperforms 100.00% of its industry peers.
The Return On Equity of GNTX (22.10%) is better than 95.12% of its industry peers.
GNTX's Return On Invested Capital of 22.04% is amongst the best of the industry. GNTX outperforms 98.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GNTX is significantly above the industry average of 9.42%.
The last Return On Invested Capital (22.04%) for GNTX is above the 3 year average (17.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.53%
ROE 22.1%
ROIC 22.04%
ROA(3y)15.44%
ROA(5y)16.25%
ROE(3y)17.26%
ROE(5y)18.17%
ROIC(3y)17.11%
ROIC(5y)17.91%

1.3 Margins

With an excellent Profit Margin value of 18.10%, GNTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of GNTX has declined.
With an excellent Operating Margin value of 21.42%, GNTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GNTX's Operating Margin has declined in the last couple of years.
GNTX's Gross Margin of 33.90% is amongst the best of the industry. GNTX outperforms 90.24% of its industry peers.
In the last couple of years the Gross Margin of GNTX has declined.
Industry RankSector Rank
OM 21.42%
PM (TTM) 18.1%
GM 33.9%
OM growth 3Y-3.76%
OM growth 5Y-4.89%
PM growth 3Y-3.29%
PM growth 5Y-5.12%
GM growth 3Y-2.78%
GM growth 5Y-2.5%

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GNTX is creating value.
Compared to 1 year ago, GNTX has less shares outstanding
Compared to 5 years ago, GNTX has less shares outstanding
GNTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

GNTX has an Altman-Z score of 15.42. This indicates that GNTX is financially healthy and has little risk of bankruptcy at the moment.
GNTX has a Altman-Z score of 15.42. This is amongst the best in the industry. GNTX outperforms 97.56% of its industry peers.
There is no outstanding debt for GNTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.42
ROIC/WACC2.41
WACC9.16%

2.3 Liquidity

A Current Ratio of 3.69 indicates that GNTX has no problem at all paying its short term obligations.
GNTX has a better Current ratio (3.69) than 92.68% of its industry peers.
GNTX has a Quick Ratio of 2.11. This indicates that GNTX is financially healthy and has no problem in meeting its short term obligations.
GNTX has a Quick ratio of 2.11. This is amongst the best in the industry. GNTX outperforms 89.02% of its industry peers.
Industry RankSector Rank
Current Ratio 3.69
Quick Ratio 2.11

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.36% over the past year.
The Earnings Per Share has been growing slightly by 2.45% on average over the past years.
The Revenue has grown by 33.91% in the past year. This is a very strong growth!
Measured over the past years, GNTX shows a small growth in Revenue. The Revenue has been growing by 4.62% on average per year.
EPS 1Y (TTM)9.36%
EPS 3Y8.51%
EPS 5Y2.45%
EPS Q2Q%17.78%
Revenue 1Y (TTM)33.91%
Revenue growth 3Y10.85%
Revenue growth 5Y4.62%
Sales Q2Q%5.67%

3.2 Future

GNTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.66% yearly.
GNTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.91% yearly.
EPS Next Y3.16%
EPS Next 2Y7.59%
EPS Next 3Y8.21%
EPS Next 5Y9.66%
Revenue Next Year4.31%
Revenue Next 2Y5.11%
Revenue Next 3Y5.28%
Revenue Next 5Y4.91%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.59, GNTX is valued correctly.
GNTX's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of GNTX to the average of the S&P500 Index (27.20), we can say GNTX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.69, the valuation of GNTX can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GNTX is on the same level as its industry peers.
GNTX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 15.59
Fwd PE 13.69

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GNTX indicates a slightly more expensive valuation: GNTX is more expensive than 63.41% of the companies listed in the same industry.
62.20% of the companies in the same industry are cheaper than GNTX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.47
EV/EBITDA 8.84

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GNTX does not grow enough to justify the current Price/Earnings ratio.
GNTX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.93
PEG (5Y)6.35
EPS Next 2Y7.59%
EPS Next 3Y8.21%

5

5. Dividend

5.1 Amount

GNTX has a Yearly Dividend Yield of 1.65%. Purely for dividend investing, there may be better candidates out there.
GNTX's Dividend Yield is slightly below the industry average, which is at 4.24.
Compared to the average S&P500 Dividend Yield of 2.36, GNTX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

The dividend of GNTX has a limited annual growth rate of 2.19%.
GNTX has been paying a dividend for at least 10 years, so it has a reliable track record.
GNTX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.19%
Div Incr Years0
Div Non Decr Years21

5.3 Sustainability

GNTX pays out 20.79% of its income as dividend. This is a sustainable payout ratio.
GNTX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP20.79%
EPS Next 2Y7.59%
EPS Next 3Y8.21%

GENTEX CORP

NASDAQ:GNTX (12/20/2024, 8:15:13 PM)

After market: 29.15 0 (0%)

29.15

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-25 2024-10-25/bmo
Earnings (Next)01-24 2025-01-24/amc
Inst Owners95.97%
Inst Owner Change0.24%
Ins Owners0.21%
Ins Owner Change0%
Market Cap6.63B
Analysts77.65
Price Target35.21 (20.79%)
Short Float %2.66%
Short Ratio4.45
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Dividend Growth(5Y)2.19%
DP20.79%
Div Incr Years0
Div Non Decr Years21
Ex-Date01-08 2025-01-08 (0.12)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.52%
Min EPS beat(2)-29.75%
Max EPS beat(2)8.7%
EPS beat(4)2
Avg EPS beat(4)-3.37%
Min EPS beat(4)-29.75%
Max EPS beat(4)10.56%
EPS beat(8)5
Avg EPS beat(8)0.52%
EPS beat(12)7
Avg EPS beat(12)-1.75%
EPS beat(16)8
Avg EPS beat(16)-3.29%
Revenue beat(2)1
Avg Revenue beat(2)-4.33%
Min Revenue beat(2)-9.41%
Max Revenue beat(2)0.75%
Revenue beat(4)2
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-9.41%
Max Revenue beat(4)2.99%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)6
Avg Revenue beat(16)-1.43%
PT rev (1m)-1.02%
PT rev (3m)-6.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.28%
EPS NY rev (1m)0.05%
EPS NY rev (3m)-2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.91%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.79%
Valuation
Industry RankSector Rank
PE 15.59
Fwd PE 13.69
P/S 2.25
P/FCF 19.47
P/OCF 12.91
P/B 2.74
P/tB 3.67
EV/EBITDA 8.84
EPS(TTM)1.87
EY6.42%
EPS(NY)2.13
Fwd EY7.31%
FCF(TTM)1.5
FCFY5.14%
OCF(TTM)2.26
OCFY7.74%
SpS12.98
BVpS10.63
TBVpS7.95
PEG (NY)4.93
PEG (5Y)6.35
Profitability
Industry RankSector Rank
ROA 19.53%
ROE 22.1%
ROCE 25.78%
ROIC 22.04%
ROICexc 24%
ROICexgc 32.93%
OM 21.42%
PM (TTM) 18.1%
GM 33.9%
FCFM 11.54%
ROA(3y)15.44%
ROA(5y)16.25%
ROE(3y)17.26%
ROE(5y)18.17%
ROIC(3y)17.11%
ROIC(5y)17.91%
ROICexc(3y)19.41%
ROICexc(5y)21.45%
ROICexgc(3y)28.74%
ROICexgc(5y)32.89%
ROCE(3y)20.01%
ROCE(5y)20.94%
ROICexcg growth 3Y-6.95%
ROICexcg growth 5Y-9.27%
ROICexc growth 3Y-3.18%
ROICexc growth 5Y-6.59%
OM growth 3Y-3.76%
OM growth 5Y-4.89%
PM growth 3Y-3.29%
PM growth 5Y-5.12%
GM growth 3Y-2.78%
GM growth 5Y-2.5%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 185.4%
Cap/Sales 5.86%
Interest Coverage 250
Cash Conversion 70.78%
Profit Quality 63.74%
Current Ratio 3.69
Quick Ratio 2.11
Altman-Z 15.42
F-Score7
WACC9.16%
ROIC/WACC2.41
Cap/Depr(3y)143.95%
Cap/Depr(5y)113.8%
Cap/Sales(3y)6.76%
Cap/Sales(5y)5.66%
Profit Quality(3y)74.58%
Profit Quality(5y)88.53%
High Growth Momentum
Growth
EPS 1Y (TTM)9.36%
EPS 3Y8.51%
EPS 5Y2.45%
EPS Q2Q%17.78%
EPS Next Y3.16%
EPS Next 2Y7.59%
EPS Next 3Y8.21%
EPS Next 5Y9.66%
Revenue 1Y (TTM)33.91%
Revenue growth 3Y10.85%
Revenue growth 5Y4.62%
Sales Q2Q%5.67%
Revenue Next Year4.31%
Revenue Next 2Y5.11%
Revenue Next 3Y5.28%
Revenue Next 5Y4.91%
EBIT growth 1Y38.28%
EBIT growth 3Y6.67%
EBIT growth 5Y-0.49%
EBIT Next Year25.6%
EBIT Next 3Y13.69%
EBIT Next 5Y11.76%
FCF growth 1Y111.26%
FCF growth 3Y-5.1%
FCF growth 5Y-5.4%
OCF growth 1Y71.58%
OCF growth 3Y4.97%
OCF growth 5Y-0.55%